Y-3 FOR INJECTION

Clinical trials for Y-3 FOR INJECTION explained in plain language.

Never miss a new study

Get alerted when new Y-3 FOR INJECTION trials appear

Sign up with your email to follow new studies for Y-3 FOR INJECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Scientists test new Shot's safety with common pills

Knowledge-focused Completed

This early study aimed to see if a new injectable drug called Y-3 interacts with three common oral medications: repaglinide (for diabetes), warfarin (a blood thinner), and omeprazole (for heartburn). Researchers enrolled 24 healthy Chinese participants to measure how the body pro…

Matched conditions: Y-3 FOR INJECTION

Phase: PHASE1 • Sponsor: Neurodawn Pharmaceutical Co., Ltd. • Aim: Knowledge-focused

Last updated Mar 30, 2026 14:30 UTC

Y-3 FOR INJECTION

Get alerted when new Y-3 FOR INJECTION trials appear

Scientists test new Shot's safety with common pills